Target intelligence / Profile preview

G protein subunit alpha i2 pseudogene 2 (GNAI2P2)

Target: GNAI2P2
Molecular classification: Other (pseudogene)

Overview

GNAI2P2 is annotated as a pseudogene in the human genome, related in sequence to GNAI2, which encodes the functional G protein subunit alpha i2. As a pseudogene, GNAI2P2 does not produce a functional protein product and has no identified physiological, pathological, or pharmacological role[4]. It is not considered a therapeutic target, and its inclusion in drug discovery or target lists would be erroneous.

Other names: G protein subunit alpha i2 pseudogene 2GNAI2P2guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 pseudogene 2

Beyond the preview

Go deeper on G protein subunit alpha i2 pseudogene 2 (GNAI2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein subunit alpha i2 pseudogene 2 (GNAI2P2).

Explore the full profile